e-learning
resources
Vienna 2012
Monday, 03.09.2012
Respiratory infections: prognosis and outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Thrombin generation test – As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis
T. Martynenko, I. Balatskaya, S. Yakov, M. Aleksey, O. Rusakova, A. Grebenyuk (Barnaul, Russian Federation)
Source:
Annual Congress 2012 - Respiratory infections: prognosis and outcome
Session:
Respiratory infections: prognosis and outcome
Session type:
Thematic Poster Session
Number:
2482
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Martynenko, I. Balatskaya, S. Yakov, M. Aleksey, O. Rusakova, A. Grebenyuk (Barnaul, Russian Federation). Thrombin generation test – As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis. Eur Respir J 2012; 40: Suppl. 56, 2482
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Middle-long term pulmonary abnormalities after severe COVID-19 pneumonia which required invasive ventilation
Related content which might interest you:
Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018
The correlation between D-dimer and pneumonia severity in H
1
N
1
patients
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010
Pneumococcal pneumonia – Are the new severity scores more accurate in predicting adverse outcomes?
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011
Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005
Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012
Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021
Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007
Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012
Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009
Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019
D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006
Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011
Thrombotic disorders (blood coagulation test and Padua Prediction Score for risk of lung thrombosis)in hospitalized patients with community-acquired pneumonia (CAP)
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018
Analysis of prevalence of depression in patients with tuberculosis and pneumonia – Is depression consequance only in chronic clinical failure ?
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010
Acute respiratory distress syndrome (ARDS) – Manifestation of onset in an immunocompetent patient with pleuropulmonary tuberculosis (TB)
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002
Outcome analysis of ‘do not resuscitate‘ versus ‘full resuscitation‘ patients with an acute exacerbation of COPD treated with noninvasive ventilation in a pulmonary unit
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept